Sonoma Pharmaceuticals, Inc. Quarterly Debt-to-equity in % from Q4 2011 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Sonoma Pharmaceuticals, Inc. quarterly Debt-to-equity history and growth rate from Q4 2011 to Q3 2024.
  • Sonoma Pharmaceuticals, Inc. Debt-to-equity for the quarter ending September 30, 2024 was 145 %, a 15.4% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 145 +19.3 +15.4% Sep 30, 2024
Q2 2024 141 +21.9 +18.3% Jun 30, 2024
Q1 2024 129 +10.3 +8.72% Mar 31, 2024
Q4 2023 119 -3.09 -2.53% Dec 31, 2023
Q3 2023 126 +23.9 +23.4% Sep 30, 2023
Q2 2023 119 +28.1 +30.8% Jun 30, 2023
Q1 2023 118 +17.7 +17.6% Mar 31, 2023
Q4 2022 122 +12.6 +11.5% Dec 31, 2022
Q3 2022 102 +2.82 +2.85% Sep 30, 2022
Q2 2022 91.4 -2.02 -2.16% Jun 30, 2022
Q1 2022 101 +26.7 +36% Mar 31, 2022
Q4 2021 109 +37.5 +52.3% Dec 31, 2021
Q3 2021 99 +26.7 +36.9% Sep 30, 2021
Q2 2021 93.4 +20.5 +28.2% Jun 30, 2021
Q1 2021 74 +7.94 +12% Mar 31, 2021
Q4 2020 71.8 +21.5 +42.6% Dec 31, 2020
Q3 2020 72.3 +28.1 +63.5% Sep 30, 2020
Q2 2020 72.9 +34.5 +90% Jun 30, 2020
Q1 2020 66.1 +31.9 +93.2% Mar 31, 2020
Q4 2019 50.4 +21.3 +73.2% Dec 31, 2019
Q3 2019 44.2 +14.9 +50.7% Sep 30, 2019
Q2 2019 38.3 +11 +40.1% Jun 30, 2019
Q1 2019 34.2 +9.67 +39.4% Mar 31, 2019
Q4 2018 29.1 +6.48 +28.7% Dec 31, 2018
Q3 2018 29.3 +8.49 +40.7% Sep 30, 2018
Q2 2018 27.4 +4.61 +20.3% Jun 30, 2018
Q1 2018 24.5 -2.06 -7.75% Mar 31, 2018
Q4 2017 22.6 -9.61 -29.8% Dec 31, 2017
Q3 2017 20.8 -19.8 -48.7% Sep 30, 2017
Q2 2017 22.8 -11.8 -34.1% Jun 30, 2017
Q1 2017 26.6 -3.91 -12.8% Mar 31, 2017
Q4 2016 32.2 +4.64 +16.8% Dec 31, 2016
Q3 2016 40.6 +9.7 +31.4% Sep 30, 2016
Q2 2016 34.6 +0.56 +1.65% Jun 30, 2016
Q1 2016 30.5 -9.15 -23.1% Mar 31, 2016
Q4 2015 27.6 -24.3 -46.9% Dec 31, 2015
Q3 2015 30.9 -32.3 -51.1% Sep 30, 2015
Q2 2015 34 -61.3 -64.3% Jun 30, 2015
Q1 2015 39.7 -116 -74.5% Mar 31, 2015
Q4 2014 51.9 -208 -80% Dec 31, 2014
Q3 2014 63.2 -222 -77.9% Sep 30, 2014
Q2 2014 95.3 -323 -77.2% Jun 30, 2014
Q1 2014 155 -418 -72.9% Mar 31, 2014
Q4 2013 260 -1.68K -86.6% Dec 31, 2013
Q3 2013 286 +5K Sep 30, 2013
Q2 2013 419 +7.39K Jun 30, 2013
Q1 2013 573 +8.12K Mar 31, 2013
Q4 2012 1.93K +398 +25.9% Dec 31, 2012
Q3 2012 -4.72K Sep 30, 2012
Q2 2012 -6.97K Jun 30, 2012
Q1 2012 -7.54K Mar 31, 2012
Q4 2011 1.54K Dec 31, 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.